Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia

NCT00492336 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: rasagiline (Pharmacodynamics)
DRUG: Placebo

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]